about
Protein binding and signaling properties of RIN1 suggest a unique effector functionDownregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cellsThe role of STATs in myeloid differentiation and leukemia.Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNARecent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory.Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.Modeling Philadelphia chromosome positive leukemias.Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.Gastric cancer cell lines AGS before and after CD40 signal activating.Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase.BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.Regulation of cell cycle entry and G1 progression by CSF-1.Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma.Do cells need CDK2 and ... Bcr-Abl?Haemopoietic transformation by the TEL/ABL oncogene.Chronic myelogenous leukemia molecular signature.
P2860
Q24319548-5D879604-C8FB-4050-A8CD-33847FE60CFEQ31055456-D039198A-8328-4765-A199-EE39358A1C4AQ33941366-9D4CF9B3-1749-4A72-A958-795F1D733CBEQ34047859-B2EA54BF-5610-4D31-AC22-055EB00DDAC0Q34167898-15912F2A-3ED0-4704-9BBE-76018EB700C1Q34235845-2D8D4A69-56ED-448F-BB5C-274E638B095EQ34250223-7711BAD6-9F16-4F97-8DEA-8523E455182CQ34283905-32095821-7388-4200-93F8-8E7FCF02F9BAQ34405446-A2257C41-57CA-4F83-97E7-B9CBF1C0C16BQ37591815-0866730C-0963-40E1-B2F1-9D94DD56F5AFQ38941081-A454B7A5-22C2-4939-AAA5-949EB3A57A33Q39393465-E2522B84-B01D-4D89-9898-26D879A79501Q40024199-C77A61E5-5596-478C-A27E-7C9131AFEF58Q40852113-D0E11A7B-823D-4875-A2BF-7D8CD384C802Q41289882-1F7C5A2F-04BE-4E2C-BDF6-CF6747308A20Q41890375-3D50FB57-0CC2-46EC-8953-B51F0DDB8233Q44699399-54131D4B-7648-4922-8001-B10A4077F747Q47720679-39C3A265-EB1D-48FC-8190-381E448F953EQ47821781-83249097-4DC5-4327-B2D6-EF34AF863CB8
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Signaling by ABL oncogenes through cyclin D1.
@ast
Signaling by ABL oncogenes through cyclin D1.
@en
type
label
Signaling by ABL oncogenes through cyclin D1.
@ast
Signaling by ABL oncogenes through cyclin D1.
@en
prefLabel
Signaling by ABL oncogenes through cyclin D1.
@ast
Signaling by ABL oncogenes through cyclin D1.
@en
P2093
P2860
P356
P1476
Signaling by ABL oncogenes through cyclin D1.
@en
P2093
J McLaughlin
M F Roussel
P2860
P304
P356
10.1073/PNAS.92.21.9540
P407
P577
1995-10-01T00:00:00Z